ACIP: Acronyms for Vaccines
Printer friendly version of Vaccine Acronyms[5 pages]
Advisory Committee on Immunization Practices
Vaccines Included in the Immunization Schedules for Children, Adolescents, and Adults
Following is a table of standardized vaccine acronyms, which was developed jointly by staff of the Centers for Disease Control and Prevention, ACIP Work Groups, the editor of the Morbidity and Mortality Weekly Report (MMWR), the editor of Epidemiology and Prevention of Vaccine-Preventable Diseases (the "Pink Book"), ACIP members, and liaison organizations to the ACIP.
These acronyms are intended to provide a uniform approach to vaccine references used in ACIP Recommendations that are published in the MMWR, the Pink Book, and the American Academy of Pediatrics Red Book; and in the U.S. immunization schedules for children, adolescents, and adults.
Updated May 2015
Vaccine | Acronym* | Trade Name | |
---|---|---|---|
Diphtheria, tetanus and pertussis-containing vaccines P=Pediatric A=Adult |
|||
Diphtheria and tetanus toxoids adsorbed (P) | DT | several manufacturers† | |
Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (P) | DTaP | Daptacel, Infanrix |
|
Tetanus and diphtheria toxoids adsorbed (A) | Td | Tenivac, Decavac, generic |
|
Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (A) | Tdap | Adacel, Boostrix |
|
Tetanus toxoid (P, A) | TT | generic | |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B and inactivated poliovirus vaccine (P) | DTaP-HepB-IPV | Pediarix | |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (P) | DTaP-IPV | Kinrix Quadracel | |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Haemophilus influenzae type b conjugate vaccine (P) | DTaP-IPV/Hib | Pentacel | |
Haemophilus influenzae type b-containing vaccines§ | |||
Haemophilus influenzae type b conjugate vaccine | Hib | PedvaxHIB, Hiberix, ActHIB |
|
Haemophilus influenzae type b conjugate and hepatitis B vaccine | Hib-HepB | Comvax | |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Haemophilus influenzae type b conjugate vaccine | DTaP-IPV/Hib | Pentacel | |
Bivalent meningococcal conjugate vaccine and Haemophilus influenza type b conjugate vaccine | Hib-MenCY | MenHibrix | |
Hepatitis-containing vaccines | |||
Hepatitis A vaccine | HepA | Havrix, Vaqta |
|
Hepatitis B vaccine | HepB | Engerix-B, Recombivax HB |
|
Hepatitis A and hepatitis B vaccine | HepA-HepB | Twinrix | |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B and inactivated poliovirus vaccine | DTaP-HepB-IPV | Pediarix | |
Haemophilus influenzae type b conjugate and hepatitis B vaccine | Hib-HepB | Comvax | |
Herpes zoster (shingles) vaccine | |||
Herpes zoster (shingles) vaccine | HZV | Zostavax | |
Human papillomavirus vaccines | |||
Human papillomavirus vaccine (nonavalent) | 9vHPV | Gardasil 9 | |
Human papillomavirus vaccine (quadrivalent) | 4vHPV | Gardasil | |
Human papillomavirus vaccine (bivalent) | 2vHPV | Cervarix | |
Influenza vaccines | |||
Inactivated influenza vaccine | IIV | several mfrs** | |
Trivalent inactivated influenza vaccine | IIV3 | several mfrs | |
Quadrivalent inactivated influenza vaccine | IIV4 | several mfrs | |
Trivalent recombinant influenza vaccine | RIV3 | FluBlok | |
Trivalent cell culture based inactivated influenza vaccine | ccIIV3 | Flucelvax | |
Live attenuated influenza vaccine | LAIV | FluMist Quadrivalent | |
Measles, mumps and rubella-containing vaccines | |||
Measles, mumps, and rubella vaccine | MMR | M-M-R II | |
Measles, mumps, rubella, and varicella vaccine | MMRV | ProQuad | |
Meningococcal-containing vaccines¶ | |||
Meningococcal conjugate vaccines | |||
Quadrivalent meningococcal conjugate vaccine | MenACWY or MCV4 | Menactra Menveo |
|
Bivalent meningococcal conjugate vaccine and Haemophilus influenzae type b conjugate vaccine | Hib-MenCY | MenHibrix | |
Meningococcal polysaccharide vaccine (quadrivalent) | MPSV4 | Menomune | |
Serogroup B meningococcal vaccines | MenB | Bexsero Trumenba |
|
Pneumococcal vaccines | |||
Pneumococcal conjugate vaccine (7-valent) | PCV7 | Prevnar | |
Pneumococcal conjugate vaccine (13-valent) | PCV13 | Prevnar 13 | |
Pneumococcal polysaccharide vaccine (23-valent) | PPSV23 | Pneumovax 23 | |
Poliovirus-containing vaccines | |||
Inactivated poliovirus vaccine | IPV | Ipol | |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine | DTaP-IPV | Kinrix Quadracel |
|
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B and inactivated poliovirus vaccine | DTaP-HepB-IPV | Pediarix | |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Haemophilus influenzae type b conjugate vaccine | DTaP-IPV/Hib | Pentacel | |
Rotavirus vaccines | |||
Rotavirus vaccine (monovalent) | RV1 | Rotarix | |
Rotavirus vaccine (pentavalent) | RV5 | RotaTeq | |
Varicella-containing vaccines | |||
Varicella vaccine | VAR | Varivax | |
Measles, mumps, rubella, and varicella vaccine | MMRV | ProQuad | |
Herpes zoster (shingles) vaccine | HZV | Zostavax |
* In descriptions of combination vaccines, dash (-) indicates: products in which the active components are supplied in their final (combined) form by the manufacturer; slash ( / ) indicates: products in which active components must be mixed by the user.
† several manufacturers; for complete listing, see U.S. Vaccines [4 pages] and U.S. Vaccine Names
§ For additional Hib vaccine acronyms, see Haemophilus influenzae type b Vaccines Acronyms.
¶ For additional meningococcal vaccine acronyms, see Meningococcal Vaccines Acronyms table.
** For more information on IIV flu vaccines, see the flu vaccines table.
Haemophilus influenza type b Vaccines Acronyms
Three monovalent Haemophilus influenzae type b (Hib) conjugate vaccines are available in the U.S.:
- ActHIB® (Sanofi Pasteur)
- PedvaxHIB® (Merck)
- Hiberix® (GlaxoSmithKline)
Alternative acronyms for these products are explained in this table:
Acronym | Product Name | Additional Information |
---|---|---|
PRP-T | ActHIB or Hiberix |
May be used to designate ActHIB or Hiberix in scientific publications, or on schedules when the brand name is not used. Indicates the Hib polysaccharide PRP (polyribosyl-ribitol-phosphate) and includes the extension “T” to indicate the protein carrier (tetanus toxoid). (PRP-T is the Hib component in the combination vaccines Pentacel® and MenHibrix®.) |
PRP-OMP | PedvaxHIB | May be used to designate PedvaxHIB in scientific publications or on schedules when the brand name is not used. Indicates the Hib polysaccharide PRP (polyribosyl-ribitol-phosphate) and includes the extension “OMP” to indicate the protein carrier (meningococcal group B outer membrane protein). (PRP-OMP is the Hib component in the combination vaccine Comvax®.) |
Meningococcal Vaccines Acronyms
Six licensed products containing meningococcal antigen are available in the U.S.:
- Menomune® (Sanofi Pasteur): a quadrivalent (serogroups A, C, W & Y), polysaccharide vaccine,
- Menactra® (Sanofi Pasteur) and Menveo® (Novartis): quadrivalent (serogroups A, C, W & Y) conjugate vaccines, and
- MenHibrix® (GlaxoSmithKline): a Haemophilus influenzae type b/bivalent (serogroups C & Y) meningococcal conjugate combination vaccine.
- Trumenba® (Pfizer) and Bexsero® (Novartis): serogroup B meningococcal vaccines
Alternative acronyms for these products are explained in this table:
Vaccine Type | Acronym | Product Name | Additional Information |
---|---|---|---|
Meningococcal (Quadrivalent) Conjugate |
MenACWY or MCV4 |
Menactra or Menveo |
These two acronyms may be used for either or both quadrivalent conjugate vaccines, on vaccination records, schedules, or other documents when it is unnecessary to distinguish between the two products. MenACWY should be used when it is desirable to identify the 4 vaccine serogroups. |
MenACWY-D | Menactra | May be used to designate Menactra in scientific publications, or when it is necessary to distinguish between the two quadrivalent vaccines. Includes the extension “D” to indicate the protein carrier (diphtheria toxoid). |
|
MenACWY-CRM or MenACWY-CRM197 |
Menveo | May be used to designate Menveo in scientific publications, or when it is necessary to distinguish between the two quadrivalent vaccines. Includes the extension “CRM” or “CRM197” to indicate the protein carrier (a non-toxic mutant of diphtheria toxin). |
|
Hib/ Meningococcal (Bivalent) Combination |
Hib-MenCY | MenHibrix | The standard acronym for MenHibrix, used in most situations. |
Hib-MenCY-TT | MenHibrix | This alternative acronym identifies the protein carrier (tetanus toxoid). |
|
Meningococcal (Quadrivalent) Polysaccharide |
MPSV4 or MPSV |
Menomune | Either acronym identifies the quadrivalent polysaccharide vaccine. |
Serogroup B Meningococcal | MenB | Trumenba or Bexsero |
This acronym may be used for either or both serogroup B meningococcal vaccines on vaccination records, schedules, or other documents when it is unnecessary to distinguish between the two products. |
MenB-FHbp | Trumenba | May be used to designation Trumenba in scientific publications or when it is necessary to distinguish between the two serogroup B meningococcal vaccines. Includes the extension “FHbp” to indicate the vaccine is composed of two recombinant lipidated Factor H binding protein variants. | |
MenB-4C | Bexsero | May be used to designate Bexsero in scientific publications or when it is necessary to distinguish between the two serogroup B meningococcal vaccines. Includes the extension “4C” to indicate the vaccine is composed of 4 components (NHBA, NadA, FHbp, and OMV containing PorA P1.4). |
- Page last reviewed: April 15, 2016
- Page last updated: May 5, 2015
- Content source: